loader2
Partner With Us NRI

Aarti Pharmalabs Ltd share Price Today

Company details

591.80
611.80
320.30
638.75
6M Return 25.11%
1Y Return 56.26%
Mkt Cap.(Cr) 5,493.30
Volume 161,379
Div Yield 0.49%
OI
-
OI Chg %
-
Volume 161,379

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Aarti Pharmalabs Ltd shares SWOT Analysis

Resistance and support

R1 614.7
R2 623.3
R3 634.7
Pivot

603.25

S1 594.7
S2 583.3
S3 574.7
EMA SMA
583.2
552.1
522.3
480.0
587.8
539.2
516.7
479.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
QUANT MUTUAL FUND Bulk Purchase 2024-05-22 575.83 1051000 NSE
BARON EMERGING MARKETS FUND Bulk Sell 2024-05-22 573 861792 NSE
GRAVITON RESEARCH CAPITAL LLP Bulk Purchase 2024-05-14 570.75 490444 NSE
Name Category Shares
Rashesh Chandrakant Gogri PROMOTER 4.23%
Renil Rajendra Gogri PROMOTER 3.08%
Mirik Rajendra Gogri PROMOTER 3.08%
Jaya Chandrakant Gogri PROMOTER 2.97%
Hetal Gogri Gala PROMOTER 2.89%
Sarla Shantilal Shah PROMOTER 2.69%
Rajendra Vallabhaji Gogri PROMOTER 1.57%
Nehal Garewal PROMOTER 1.24%
Nikhil Parimal Desai PROMOTER 0.85%
Aarnav Rashesh Gogri PROMOTER 0.61%
Aashay Rashesh Gogri PROMOTER 0.61%
Manisha Rashesh Gogri PROMOTER 0.61%
Bhavna Shah Lalka PROMOTER 0.57%
Arti Rajendra Gogri PROMOTER 0.52%
Anushakti Enterprise Private Limited PROMOTER 3.28%
LABDHI BUSINESS TRUST (Saswat Trusteeship Private Limited) PROMOTER 3.14%
ORCHID FAMILY TRUST (Relacion Trusteeship Services Private Limited) PROMOTER 1.82%
TULIP FAMILY TRUST (Gloire Trusteeship Services Private Limited) PROMOTER 1.82%
Safechem Enterprises Private Limited PROMOTER 1.61%
MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) PROMOTER 1.44%
Heena Family Private Trust (Barclays Wealth Trustees India Private Limited) PROMOTER 0.92%
Bhavna Family Private Trust (Barclays Wealth Trustees India Pvt Ltd) PROMOTER 0.89%
JASMINE FAMILY TRUST (Relacion Trusteeship Services Private Limited) PROMOTER 0.76%
Alchemie Financial Services Limited PROMOTER 0.74%
LOTUS FAMILY TRUST (Gloire Trusteeship Services Private Limited) PROMOTER 0.69%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Aarti Pharmalabs Ltd Stocks COMPARISON

Financials( in Cr) Aarti Pharmalabs Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 606.15 1,516.00 1,564.75 4,588.60 1,109.55
% Change 1.63 0.34 1.31 -0.11 1.75
Mcap Cr 5,493.30 363,739.19 126,332.75 121,813.11 111,646.69
Revenue TTM Cr 1,945.23 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 193.49 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 25.34 36.34 29.68 76.10 28.94
1 Year Return 56.26 53.43 59.42 31.57 114.34
ROCE 16.09 16.79 14.76 19.30 16.25
ROE 13.14 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,558.48 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 33,119.99 -408.46
LAST 3M 113,155.52 -36,230.77
LAST 6M 183,603.09 -15,050.11
LAST 12M 290,144.87 98,834.05

Aarti Pharmalabs Ltd Information

Stock PE (TTM)
25.34
Promoter Holding
46.46%
Book Value
193.8785
ROCE
16.09%
ROE
13.14%
Description
  • Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022. The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity `Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date. Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023. 9,06,26,008 Equity Shares of Rs 5/- each got listed effective January 30, 2023.

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 543748
NSE Code : AARTIPHARM
Book Closure Date (Month) :
BSE Group : A
ISIN : INE0LRU01027

FAQ’s on Aarti Pharmalabs Ltd Shares

You can buy Aarti Pharmalabs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aarti Pharmalabs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 03:56 PM the closing price of Aarti Pharmalabs Ltd was Rs.606.15.

The latest PE ratio of Aarti Pharmalabs Ltd as of Jun 14, 2024 03:56 PM is 25.34

The latest PB ratio of Aarti Pharmalabs Ltd as of Jun 14, 2024 03:56 PM is 0.32

The 52-week high of Aarti Pharmalabs Ltd share price is Rs. 638.75 while the 52-week low is Rs. 320.30

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 03:56 PM, the market cap of Aarti Pharmalabs Ltd stood at Rs. 5,493.30.

Download App

Download Our App

Play Store App Store
market app